Mode
Text Size
Log in / Sign up
N/A N=161 Randomized Single-blind Treatment

Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors

Breast Cancer

Enrolled (actual)
161
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: Physical Activity — 145.83; 159.86; 172.94; 120.81 min/week — p=<.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Reach Plus (Behavioral); Reach Plus Phone (Behavioral); Reach Plus Message (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
Female
Sponsor
University of South Carolina
Primary completion
Mar 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Physical Activity
145.83; 159.86; 172.94; 120.81; 137.16; 135.00 <.05 sig
PRIMARY
Min/Week Objectively Measured Moderate-to-vigorous Physical Activity
46.43; 82.17; 54.62; 61.90; 68.75; 49.95 <.05 sig
SECONDARY
Breast Cancer Quality of Life
24.72; 24.86; 24.76; 24.66; 24.88; 25.12
SECONDARY
Fatigue
40.91; 42.02; 41.79; 41.33; 41.66; 41.35
SECONDARY
Mood
8.52; 8.82; 7.71; 7.73; 5.12; 7.59

Summary

Exercise adoption enhances well-being and recovery from breast cancer. Researchers trained American Cancer Society volunteers to provide exercise counseling to breast cancer survivors and the survivors increased their exercise in the short-term. This RCT examines the effects of three maintenance conditions on survivors' exercise participation at longer follow-ups. The cost-effectiveness of the three groups will be examined to guide implementation of this peer mentoring approach in community-based organizations.

Eligibility Criteria

Inclusion Criteria

Women aged 21 years or over will be eligible if they:

  • Have been diagnosed in the past 5 years with Stage 0-3 breast cancer.
  • Are able to read and speak English.
  • Are ambulatory.
  • Are sedentary (i.e., do not meet recommendations for moderate-intensity PA [30 minutes/ day or more for at least 5 days/ week] or vigorous-intensity PA [20 minutes/day or more for at least 3 days/week]
  • Are able to walk unassisted.
  • Have access to a telephone.

Exclusion Criteria

Women with:

  • More advanced disease (Stage 4).
  • Medical or psychiatric problems (e.g., substance abuse, coronary artery disease, peripheral vascular disease, diabetes, and orthopedic problems) that may interfere with protocol adherence will not be included.
  • Participants will be asked to provide consent for medical chart review to extract disease and treatment variables. Eligible participants will obtain medical clearance from their physicians.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02694640). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search